Current Advanced Therapies Based on Human Mesenchymal Stem Cells for Skin Diseases
Open Access
- 9 March 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 9
Abstract
Skin disease may be related with immunological disorders, external aggressions, or genetic conditions. Injuries or cutaneous diseases such as wounds, burns, psoriasis, and scleroderma among others are common pathologies in dermatology, and in some cases, conventional treatments are ineffective. In recent years, advanced therapies using human mesenchymal stem cells (hMSCs) from different sources has emerged as a promising strategy for the treatment of many pathologies. Due to their properties; regenerative, immunomodulatory and differentiation capacities, they could be applied for the treatment of cutaneous diseases. In this review, a total of thirteen types of hMSCs used as advanced therapy have been analyzed, considering the last 5 years (2015–2020). The most investigated types were those isolated from umbilical cord blood (hUCB-MSCs), adipose tissue (hAT-MSCs) and bone marrow (hBM-MSCs). The most studied diseases were wounds and ulcers, burns and psoriasis. At preclinical level, in vivo studies with mice and rats were the main animal models used, and a wide range of types of hMSCs were used. Clinical studies analyzed revealed that cell therapy by intravenous administration was the advanced therapy preferred except in the case of wounds and burns where tissue engineering was also reported. Although in most of the clinical trials reviewed results have not been posted yet, safety was high and only local slight adverse events (mild nausea or abdominal pain) were reported. In terms of effectiveness, it was difficult to compare the results due to the different doses administered and variables measured, but in general, percentage of wound’s size reduction was higher than 80% in wounds, Psoriasis Area and Severity Index and Severity Scoring for Atopic Dermatitis were significantly reduced, for scleroderma, parameters such as Modified Rodnan skin score (MRSC) or European Scleroderma Study Group activity index reported an improvement of the disease and for hypertrophic scars, Vancouver Scar Scale (VSS) score was decreased after applying these therapies. On balance, hMSCs used for the treatment of cutaneous diseases is a promising strategy, however, the different experimental designs and endpoints stablished in each study, makes necessary more research to find the best way to treat each patient and disease.Keywords
Funding Information
- Instituto de Salud Carlos III (PI13/02576, PI17/02083)
- Junta de Andalucía (SAS PI-0458-2016, PIGE-0242-2019)
This publication has 114 references indexed in Scilit:
- Wound Repair and RegenerationEuropean Surgical Research, 2012
- Clinical Application of Mesenchymal Stem Cells in the Treatment and Prevention of Graft-versus-Host DiseaseAdvances in Hematology, 2011
- Stromal stem cells from adipose tissue and bone marrow of age‐matched female donors display distinct immunophenotypic profilesJournal of Cellular Physiology, 2010
- Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical studyAnnals of the Rheumatic Diseases, 2010
- Histocompatibility testing of cultivated human bone marrow stromal cells – A promising step towards pre-clinical screening for allogeneic stem cell therapyCellular Immunology, 2009
- Chemokine-Mediated Migration of Skin-Derived Stem Cells: Predominant Role for CCL5/RANTESJournal of Investigative Dermatology, 2009
- Wound repair and regenerationNature, 2008
- Full-thickness tissue engineered skin constructed with autogenic bone marrow mesenchymal stem cellsScience China Life Sciences, 2007
- Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus ReportJournal of Allergy and Clinical Immunology, 2006
- Keloids and Hypertrophic ScarsDermatologic Surgery, 1999